Oppenheimer's top stock picks for the next 12 months include Viking Therapeutics, Inc. (NASDAQ:VKTX), a biotech company with promising drug candidates for liver diseases and weight loss. Despite its potential, other AI stocks may offer higher returns in a shorter timeframe.